New breast cancer drug could extend patients’ lives by 16 months
Some heartening news for breast cancer patients: a recent study has shown that Perjeta, a new breast cancer drug developed by Swiss pharmaceutical company Roche, can increase survival of women with advanced breast cancer by nearly 16 months. When cancer reaches the advanced stage, it becomes ... Read more